Aret; Edwin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aret; Edwin.The latest application filed is for "crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1- -yl)-n-(pyridin-2-yl)benzamide".

Company Profile

8.11.15

Aret; Edwin - Almere NL
Aret; Edwin - Weert NL
Aret; Edwin - CJ Almere NL
Aret; Edwin - Amsterdam N/A NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Salts and crystals Grant 11,440,911 - Wennogle , et al. September 13, 2	2022-09-13
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1- -yl)-n-(pyridin-2-yl)benzamide App 20220177476 - Blatter; Frtiz ; et al.	2022-06-09
Crystalline Forms of 4-(5-(4,7-Dimethylbenzofuran-2-YL)-1,2,4-Oxadiazol-3-YL)Benzoic Acid and Processes for Their Preparation App 20210230151 - Lawrence; Ronnie Maxwell ; et al.	2021-07-29
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide maleate Grant 11,059,829 - Blatter , et al. July 13, 2	2021-07-13
Solid Forms Of A Plasma Kallikrein Inhibitor And Salts Thereof App 20210171496 - CROWE; David Malcolm ; et al.	2021-06-10
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7- H- pyrido[3',4':4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide Grant 11,014,925 - Li , et al. May 25, 2	2021-05-25
Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation Grant 10,870,644 - Lawrence , et al. December 22, 2	2020-12-22
Crystalline Forms Of Compounds For Preventing Or Treating Sensory Hair Cell Death App 20200345705 - Johnson; Graham ; et al.	2020-11-05
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1- -yl)-N-(pyridin-2-yl)benzamide malea App 20200255437 - Kind Code	2020-08-13
Novel Salts And Crystals App 20200247805 - Kind Code	2020-08-06
Salts and crystals of ITI-007 Grant 10,654,854 - Li , et al.	2020-05-19
Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma Grant 10,640,509 - Blatter , et al.	2020-05-05
Novel Co-crystals App 20200017500 - LI; Peng ; et al.	2020-01-16
Crystalline Forms of 4-(5-(4,7-Dimethylbenzofuran-2-YL)-1,2,4-Oxadiazol-3-YL)Benzoic Acid and Processes for Their Preparation App 20190345147 - LAWRENCE; RONNIE MAXWELL ; et al.	2019-11-14
Solid Forms and Formulations of Imidazopyrazine Compound App 20190337949 - Blatter; Fritz ; et al.	2019-11-07
Novel Salts And Crystals App 20190112309 - LI; Peng ; et al.	2019-04-18
Novel Co-crystals App 20190112310 - LI; Peng ; et al.	2019-04-18
Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide Grant 10,167,291 - Blatter , et al. J	2019-01-01
Solid Forms and Formulations of Imidazopyrazine Compound App 20180208596 - Blatter; Fritz ; et al.	2018-07-26
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-- yl)-N-(pyridin-2-yl)benzamide Grant 9,796,721 - Blatter , et al. October 24, 2	2017-10-24
Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents Grant 9,637,459 - Grunenberg , et al. May 2, 2	2017-05-02
Solid Forms and Formulations of Imidazopyrazine Compound App 20170029428 - Blatter; Fritz ; et al.	2017-02-02
Sodium And Calcium Salts Of Dihydroquinazoline Derivative And Use Thereof As Antiviral Agents App 20150038514 - Grunenberg; Alfons ; et al.	2015-02-05
Crystal of a benzoxazinone compound Grant 8,883,780 - Aret November 11, 2	2014-11-11
Crystal Of A Benzoxazinone Compound App 20120101090 - Aret; Edwin	2012-04-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.